Díaz, CR, Hernández, SJ, Chaib, FB, Polo, LL, Torrecillas, LG, Ayaso, MC, Abanto, AIC, García, JP, Gamito, GM, Jiménez, D, Lecumberri, R, Artacho, PR. Impact of an emergency department nurse training intervention on the adequacy of thromboprophylaxis for venous thromboembolism: the PROTESU III study. EMERGENCIAS. 2024; 36(5)DOI:10.55633/s3me/080.2024. PMID:39364989. IF:6.300(Q1/1D).

Angeles-Sistac, D, Morán-Chorro, I, Morales-Quinteros, L. Bjørn Ibsen: What Made Intensive Care So Critical?. Cureus. 2024; 16(8)DOI:10.7759/cureus.67281. PMID:39301333. IF:(Q/D).

Angeles-Sistac, D, Izura-Gomez, M, Barguilla-Arribas, A, Sierra-Marcos, A, Moran-Chorro, I. Lance-Adams Syndrome in the Intensive Care Unit: A Case Report. Cureus. 2024; 16(4)DOI:10.7759/cureus.58241. PMID:38745818. IF:(Q/D).

Marín-Cerezuela, M, Martín-Latorre, R, Frasquet, J, Ruiz-Ramos, J, Garcia-Contreras, S, Gordón, M, Broch, MJ, Castellanos-Ortega, A, Ramirez, P. Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support. CRITICAL CARE. 2024; 28(1)DOI:10.1186/s13054-024-05126-4. PMID:39425201. IF:9.300(Q1/1D).

Salmerón, RA, Ametller, MAG, Albiach, AMJ, Sánchez, LM, Martínez, EFD, Cardús, ASI. Availability of antidotes in the primary care emergency centers of Catalonia. EMERGENCIAS. 2024; 36(1)DOI:10.55633/s3me/07.2023. PMID:38318746. IF:6.300(Q1/1D).

Ramos-Rodríguez, J, Bonete-Sánchez, M, Ruiz-Ramos, J, Calderon-Hernanz, B, Campino-Villegas, A, de Lorenzo-Pinto, A, García-Peláez, M, García-Gutiérrez, MD, García-Martin, A, Real-Campaña, JM, Ginés-Palomares, A, Such-Díaz, A, Vallvé-Alcon, E, Alonso-Ramos, H. Impact on safety and cost of pharmaceutical interventions in the emergency department (INTERPHAR): a standardized methodology for multicenter documentation. EMERGENCIAS. 2025; 37(5)DOI:10.55633/s3me/082.2025. PMID:41185476. IF:6.300(Q1/1D).

Nogué-Xarau, S, Martínez-Sánchez, L, García-Peláez, M, de Gamarra-Martínez, EF, Pi-Sala, N, Gispert-Ametller, A, Salgado-García, E, Aguilar-Salmerón, R. [Translated article] N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning. Farmacia Hospitalaria. 2026; 50(3)DOI:10.1016/j.farma.2025.10.015. PMID:41318245. IF:(Q/D).

Nogué-Xarau, S, Martínez-Sánchez, L, García-Peláez, M, de Gamarra-Martínez, EF, Pi-Sala, N, Gispert-Ametller, A, Salgado-García, E, Aguilar-Salmerón, R. N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning. Farmacia Hospitalaria. 2026; 50(3)DOI:10.1016/j.farma.2025.07.005. PMID:40835518. IF:(Q/D).

Rubio, MC, Soler-Cataluña, JJ, Campos, JLL, Navarrete, BA, González, FJC, Garin, N, Bernabéu-Morai, R, Rivasj, PC, Triguerosk, GE, Figueira-Gonçalves, JM, Gomila, AF, Mayoral, RG, Monge, GLA, Oto, MM, Martin, EM, de Miguel-Diez, J, Riesco, JA, Garcia, CR, Pérez, SS, Ecenarro, PS, Delgado, MS, Miravitlles, M. Clinical protocol for the use of biologic therapy in COPD. RESPIRATORY MEDICINE. 2026; 254DOI:10.1016/j.rmed.2026.108718. PMID:41722824. IF:3.100(Q2/4D).

Carbó, LVV, Gómez, MJE, Gómez, IRJ, Sánchez, AR, Oliveros, NV, Gil, ABG, Villegas, AC, Campillos, P, Martinez, PO, de Pourcq, JT. [Translated article] Guidelines on the perioperative management of chronic medication in surgical patients. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.11.002. PMID:41372088. IF:(Q/D).

Lopez, AD, Escrig, EV, Serrano, PS, Morillo-Verdugo, R. [Translated article] Risk stratification tool for pharmaceutical care in patients with cardiovascular disease. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.11.001. PMID:41387041. IF:(Q/D).

Carbó, LVV, Gómez, MJE, Gómez, IRJ, Sánchez, AR, Oliveros, NV, Gil, ABG, Villegas, AC, Campillos, P, Martinez, PO, De Pourcq, JT. Guidelines on the perioperative management of chronic medication in surgical patients. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.07.002. PMID:40846569. IF:(Q/D).

Lopez, AD, Escrig, EV, Serrano, PS, Morillo-Verdugo, R. Risk stratification tool for pharmaceutical care in patients with cardiovascular disease. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.07.001. PMID:40877090. IF:(Q/D).

Salvador, JFS, Gimenez-Arnau, AM, de la Fuente, EG, del Castillo, JG, Virto, AMM, Blanco, IM, Serra-Baldrich, E, Llorens, P. Managing urticaria in the emergency department: recommendations of a multidisciplinary expert panel. EMERGENCIAS. 2021; 33(4)DOI:. PMID:34251143. IF:5.345(Q1/2D).

Augustin, M, Gottlieb, AB, Lebwohl, M, Pinter, A, Warren, RB, Puig, L, Warham, R, Lambert, J, Wiegratz, S, Szilagyi, B, Blauvelt, A. Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis. Dermatology and Therapy. 2024; 14(10)DOI:10.1007/s13555-024-01261-6. PMID:39285121. IF:4.200(Q1/1D).

Tada, Y, Soliman, AM, Ishii, K, Sakuma, R, Puig, L, Davis, M, Nunag, D, Pinter, A, Imafuku, S. Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan. Dermatology and Therapy. 2024; 14(1)DOI:10.1007/s13555-023-01064-1. PMID:38019410. IF:4.200(Q1/1D).

Campos, J, Pons, G, Al-Sakkaf, AM, Lusetti, I, Pires, L, Vela, F, Ramos, E, Crisóstomo, V, Sánchez-Margallo, F, Abellán, E, Masiá, J. Lymphatic Regeneration after Popliteal Lymph Node Excision and Implantation of Aligned Nanofibrillar Collagen Scaffolds: An Experimental Rabbit Model. Journal of Functional Biomaterials. 2024; 15(8)DOI:10.3390/jfb15080235. PMID:39194673. IF:5.200(Q1/3D).

Juliebo-Jones, P, Gauhar, V, Lim, EJ, Traxer, O, Madarriaga, YQ, Castellani, D, Fong, KY, Bujons-Tur, A, Ragoori, D, Shretha, A, Vaddi, CM, Bhatia, TP, Sekerci, CA, Tanidir, Y, Teoh, JYC, Somani, BK. Outcomes and considerations for retrograde intrarenal surgery (RIRS) in the setting of multiple and large renal stones (>15 mm) in children: Findings from multicentre and real-world setting. Bjui Compass. 2024; 5(6)DOI:10.1002/bco2.357. PMID:38873356. IF:(Q/D).

Pellegrino, F, Pellegrino, A, Falagario, UG, Tozzi, M, Weston, R, Hanchanale, V, Gandaglia, G, Briganti, A, Montorsi, F, Tuderti, G, Brassetti, A, Simone, G, Izzo, A, Spena, G, Contieri, R, Perdonà, S, Tedde, A, Madonia, M, Tappero, S, Mazzone, E, Dell'Oglio, P, Galfano, A, Decaestecker, K, Dekuyper, P, Ameye, F, Lavagno, F, Marra, G, Gontero, P, Costi, C, Passaretti, G, Russo, A, Gaboardi, F, Möller, A, Sundquist, F, Olsson, M, Vaccaro, C, Mistretta, FA, Luzzago, S, Musi, G, Piccolini, A, Paciotti, M, Lughezzani, G, Buffi, NM, Checcucci, E, Alessio, P, Amparore, D, Porpiglia, F, Marino, F, Di Gianfrancesco, L, De Marchi, D, Porreca, A, Fankhauser, C, Ferro, M, Breda, A, Crivellaro, S, Wiklund, P. One year in: early European adoption of the da Vinci Single Port platform-a multi-institutional study from the European Association of Urology Robotic Urology Section Scientific Working Group. BJU INTERNATIONAL. 2026; 137(6)DOI:10.1111/bju.70193. PMID:41740983. IF:4.400(Q1/2D).

Fernández-Mardomingo, A, Subiela, JD, Medina, AA, Krajewski, W, Pichler, R, van Creij, NCH, Lucena, MDDE, de la Parra, I, Ojeda, CM, Coloma, A, Martínez, LC, Durán, PD, González-Padilla, DA, Villacampa, F, Aumatell, J, Scilipoti, P, Longoni, M, Moschini, M, de Angelis, M, Caño-Velasco, J, Contieri, R, Gallioli, A, D'Andrea, D, Acosta, EA, Ajami, T, Grobet-Jeandin, E, Del Giudice, F, Santarelli, V, Slusarczyk, A, Albisinni, S, Soria, F, Mertens, LS, Tully, K, Mari, A, Guerrero-Ramos, F, Alvarez-Maestro, M, Melendres, FA, Buisan, O, Afferi, L, Gajate, P, Guerrero, P, Saiz, A, Pradere, B, Revilla, FJB. Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups. BJU INTERNATIONAL. 2026; 137(5)DOI:10.1111/bju.70207. PMID:41773726. IF:4.400(Q1/2D).